Arrowhead Pharma Inc - COM (ARWR)

CUSIP: 042797209

Q1 2026 13F Holders as of 31 Mar 2026

Share change
-85
SEC-reported price per share
$62.70
Number of holders
1
Value change
-$5,330
Number of sells
1

Security key

042797209

Report period

Q1 2026

Institutions

1

Top holders

1

Ownership snapshot

Top reported holders of ARWR - Arrowhead Pharma Inc - COM (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
FMR LLC
Disclosed value leader
BlackRock, Inc.
Comparable rows
3/15
Latest evidence
31 Mar 2026
13D/G 13F 3/4/5 Lead comparable stake: 5.2% 12 rows are not safely comparable across share classes. 13D/G row: FMR LLC Showing 1-6 of 15 holder rows.

Quick read

FMR LLC leads the comparable SEC ownership view at 5.2%.

3 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens FMR LLC's linked filing trail.
Comparable ownership Top 3
FMR LLC 5.2%
VANGUARD CAPITAL MANAGEMENT LLC 5%
STATE STREET CORP 4.6%

Ownership % is shown only when SEC disclosures are safely comparable across share classes.

Detailed SEC evidence table Showing 1-6 of 15 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
FMR LLC
13D/G 13F
Company
5.2%
Reported 13D/G · 31 Mar 2026
$478,720,814
7,349,107 shares
$0 31 Mar 2026
VANGUARD CAPITAL MANAGEMENT LLC
13D/G
Vanguard Capital Management
5%
Reported 13D/G · 31 Mar 2026
$443,997,071
7,081,293 shares
$0 31 Mar 2026
STATE STREET CORP
13F 13D/G
Company · STATE STREET CORPORATION
4.6%
Reported 13D/G · 30 Jun 2025
$425,150,274
6,403,830 shares
— 31 Dec 2025
BlackRock, Inc.
13F
Company
13F
—
denominator unverified
$1,415,340,659
21,318,582 shares
— 31 Dec 2025
VANGUARD GROUP INC
13F
Company
13F
—
denominator unverified
$1,015,310,304
15,293,121 shares
— 31 Dec 2025
Avoro Capital Advisors LLC
13F
Company
13F
—
denominator unverified
$705,393,750
10,625,000 shares
— 31 Dec 2025
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q1 2026

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
1
Shares
104,908
Rows available
1
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q1 2026 vs Q4 2025 Across Filers

Q4 2025 holders
1
Q1 2026 holders
1
Holder diff
0
Investor Q4 2025 Shares Q1 2026 Shares Share Diff Share Chg % Q4 2025 value Q1 2026 value Value change Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .